The stock opened at $12 per share, below the $13-$15 range expected for shares of the California stent graft maker. The stock closed at $13.79 today, and slipped 2.8% to $13.40 in after-hours.
Trivascular announced last month that it hoped to raise as much as $98 million from its IPO, but at $12 per share the sale of 65 million units of stock will top out around $78 million before any over-allotments.
The Santa Rose, Calif.-based medical device company has said it plans to use the proceeds to to repay a $3.5 million promissory note, plus interest, to medtech titan Boston Scientific (NYSE:BSX). Additional funds will go toward sales & marketing efforts, expanded R&D and general corporate operations.
Trivascular’s Ovation stent graft which won FDA approval in October 2012 and has been on the European market since landing CE Mark approval in August 2010.
In case you missed it
- FDA approves Genentech’s Susvimo drug-eluting eye implant
- Ocular Therapeutix dry eye treatment trial fails to meet primary endpoint
- HHS, DOD invest more than $562M to increase COVID-19 test manufacturing
- BD adds infectious disease expert Dr. Carrie Byington to board of directors
- Baxter, Biomérieux win CE mark for test predicting persistent severe acute kidney injury
- Study finds single-use bronchoscopes reduce hospital readmission rates by half
- Medtronic hires social-media-minded chief medical officer for its gastrointestinal unit
- Boston Scientific settles patent dispute with Micro-Tech Endoscopy over hemostasis clips
- Danaher slides despite Street-beating Q3
- Eli Lilly touts data for tirzepatide compared to insulin glargine for type 2 diabetes
- DarioHealth unveils digital therapy for treating musculoskeletal conditions
- J&J Institute, DePuy Synthes launch mobile training lab for Velys robotic surgery platform
- Luminopia’s new FDA-approved therapy uses TV to treat lazy eye in kids
- Diversity in medtech: Just 21% of executive roles are held by women
- Medtronic touts data for MiniMed 780G insulin pump in children
- Medtronic warns on Percept PC implantable neurostimulators
- Abbott rises on Street-beating Q3, increased EPS guidance
- October 2021 Issue: Women in Medtech How Hologic made a major pandemic pivot: CFO Karleen Oberton reflects on key decisions and turning points of the COVID-19 pandemic. Insulet CEO Shacey Petrovic is pumped up to launch Omnipod 5 Boston Scientific’s Meghan Scanlon forecasts the future of urology There is still a long way to go to close the gender… […]
- Study finds single-use bronchoscopes reduce hospital readmission rates by halfA study of 14,228 bronchoscopy procedures found sterile, disposable scopes reduced readmission rates by more than half. The study, authored by Ambu consultant Dr. Hudson Garrett, analyzed procedures at inpatient hospitals as well as outpatient ambulatory facilities. He found that 3.6 percent of patients treated with a single-use, flexible bronchoscope were readmitted within 30 days,… […]
- Medtronic hires social-media-minded chief medical officer for its gastrointestinal unitMedtronic (NYSE:MDT) today said it has hired Dr. Austin Chiang as the first chief medical officer of the medical device maker’s gastrointestinal business. Chiang is an assistant professor of medicine at Sidney Kimmel Medical College and director of the Endoscopic Bariatric Program at Thomas Jefferson University Hospital, both in Philadelphia. He holds a master’s degree… […]
- Boston Scientific settles patent dispute with Micro-Tech Endoscopy over hemostasis clipsBoston Scientific (NYSE:BSX) said yesterday that it has resolved its patent infringement litigation against Micro-Tech Endoscopy over hemostasis clips used in endoscopy procedures. Boston Scientific said it will grant a five-year, royalty-bearing license to Ann-Arbor, Mich.-based Micro-Tech for the patented hemostasis clip technology. The clips are applied to tissue or blood vessels to stop gastrointestinal… […]
- How vapor degreasing is helping to future-proof medical device reliabilityPrecision cleaning of electronic medical devices boosts reliability. Jay Tourigny, MicroCare COVID-19 has brought the importance of wearable and remote monitoring and diagnostic devices to the forefront. But these devices, with their intricate PCBAs (printed circuit board assemblies) must deliver reliable and consistent performance, particularly as they are often used in devices that are life-sustaining.… […]
- Freudenberg Medical launches SpeakFree HME valve for laryngectomy careFreudenberg Medical today announced the commercial launch of its Blom-Singer SpeakFree heat and moisture exchange (HME) hands free valve. The device is designed for people who have undergone a total laryngectomy, or the removal of a person’s larynx or voice box, resulting in loss of speech. Carpinteria, California-based Freudenberg Medical’s InHealth Technologies unit said its… […]
- Luminopia’s new FDA-approved therapy uses TV to treat lazy eye in kidsLuminopia announced today that it received FDA de novo approval for its prescription therapy for improving vision in children with lazy eye. Cambridge, Massachusetts-based Luminopia’s prescription Luminopia One holds indication for improvement in visual acuity in children between ages four and seven with lazy eye (amblyopia) associated with anisometropia and/or mild strabismus, having received treatment… […]
- Tessy Plastics has a deal for a new campus in New YorkTessy Plastics today said it has a deal to buy a three-building campus totaling about 1.5 million square feet in Webster, New York. The three buildings — 200, 210 and 214 at 800 Phillips Road, formerly owned by Xerox — are about an hour’s drive from Skaneateles, New York-based Tessy’s other facilities in Upstate New York. The… […]
- Diversity in medtech: Just 21% of executive roles are held by womenThe prevalence of women in corporate leadership positions within the medical device industry remains low, and the rate of increase is stagnant despite new initiatives to increase diversity in the industry. Just 21% of top executives at the world’s 100 world’s biggest medical device companies are women, according to an analysis of Medical Design &… […]
- Intuitive Surgical highlights supply chain risk, addresses Medtronic’s Hugo launchIntuitive Surgical executives today said delays and price increases are working their way through the medtech supply chain, likely resulting in higher production costs in the months ahead and the potential for delayed development and regulatory activity. “I don’t think I can say it’s getting better. It’s a difficult situation and will continue for some… […]
- Intuitive Surgical names new C-suite leaders, reports Street-beating Q3Intuitive Surgical (NSDQ:ISRG) today announced changes in the ranks of its senior leadership as the surgical robotics maker released Q3 results that exceeded expectations. Sunnyvale, California-based Intuitive launched two new functional organizations — Strategy and Growth, and Global Business Services — and named leaders who will take over effective Jan. 1. Dave Rosa, a 25-year… […]